Tetrahydroaminocrin en es it fr

Tetrahydroaminocrin Brand names, Tetrahydroaminocrin Analogs

Tetrahydroaminocrin Brand Names Mixture

  • No information avaliable

Tetrahydroaminocrin Chemical_Formula


Tetrahydroaminocrin RX_link


Tetrahydroaminocrin fda sheet

Tetrahydroaminocrin msds (material safety sheet)

Tetrahydroaminocrin MSDS

Tetrahydroaminocrin Synthesis Reference

No information avaliable

Tetrahydroaminocrin Molecular Weight

198.264 g/mol

Tetrahydroaminocrin Melting Point

183.5 oC

Tetrahydroaminocrin H2O Solubility

217 mg/L

Tetrahydroaminocrin State


Tetrahydroaminocrin LogP


Tetrahydroaminocrin Dosage Forms

No information avaliable

Tetrahydroaminocrin Indication

For the treatment of mild to moderate dementia of the Alzheimer's type.

Tetrahydroaminocrin Pharmacology

Tacrine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Tacrine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, tacrine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that tacrine alters the course of the underlying dementing process.

Tetrahydroaminocrin Absorption

Tacrine is rapidly absorbed. Absolute bioavailability of tacrine is approximately 17 ± 13%.

Tetrahydroaminocrin side effects and Toxicity

No information avaliable

Tetrahydroaminocrin Patient Information

No information avaliable

Tetrahydroaminocrin Organisms Affected

Humans and other mammals